의료 영상 및 AI 기반 진단 시장 예측(-2034년) - 영상 진단법, AI기능, 도입 모델, 용도, 최종사용자, 지역별 분석

According to Stratistics MRC, the Global Medical Imaging & AI-Enhanced Diagnostics Market is accounted for $3.3 billion in 2026 and is expected to reach $38.6 billion by 2034 growing at a CAGR of 36.0% during the forecast period. Medical Imaging & AI-Enhanced Diagnostics integrates sophisticated imaging systems with artificial intelligence to strengthen disease identification, diagnostic accuracy, and treatment decisions. AI-powered tools evaluate X-rays, CT, MRI, ultrasound, and other diagnostic images to recognize abnormalities, identify diseases at earlier stages, and assist medical professionals. Machine learning and deep learning technologies facilitate automated interpretation, pattern detection, and image-based measurements. Increasing healthcare digitization, rising diagnostic imaging workloads, growing emphasis on precision medicine, and continuous AI innovation are supporting wider adoption of these solutions among hospitals, diagnostic laboratories, imaging centers, and other healthcare providers.

According to the U.S. FDA, more than 1,000 AI/ML-enabled medical devices had been authorized by 2024/2025, demonstrating the rapid expansion of clinically regulated AI technologies in healthcare. Medical imaging and radiology represent a major portion of these authorized applications.

Market Dynamics:

Driver:

Growing demand for early and accurate disease detection

Increasing demand for faster and more precise disease identification is significantly supporting the Medical Imaging & AI-Enhanced Diagnostics Market. AI-enabled imaging technologies help healthcare professionals detect abnormalities and disease indicators earlier, enabling quicker diagnosis and treatment planning. Advanced deep learning systems can process large volumes of medical images, identify intricate patterns, and highlight findings that could be challenging to recognize through conventional interpretation. The growing burden of chronic illnesses, expanding elderly populations, and rising use of diagnostic imaging are prompting hospitals and imaging facilities to implement AI-based solutions that enhance workflow efficiency, diagnostic reliability, and clinical decision-making.

Restraint:

High implementation costs and infrastructure requirements

Significant investment requirements and infrastructure challenges can limit expansion of the Medical Imaging & AI-Enhanced Diagnostics Market. AI-powered imaging solutions may require high-performance computing systems, specialized applications, secure data infrastructure, and integration with established healthcare technologies. Hospitals and diagnostic facilities must also allocate resources for equipment modernization, cybersecurity measures, employee training, software updates, and ongoing maintenance. Furthermore, connecting AI platforms with legacy imaging equipment and electronic health records can create technical complexities, prolong implementation, and increase costs, potentially delaying broader market adoption.

Opportunity:

Expansion of AI-powered imaging in emerging healthcare markets

Increasing deployment of artificial intelligence-based imaging technologies in emerging healthcare markets creates substantial growth opportunities for the Medical Imaging & AI-Enhanced Diagnostics Market. Developing countries are strengthening digital healthcare infrastructure, upgrading diagnostic equipment, and adopting advanced clinical solutions to expand diagnostic capabilities. Rising healthcare spending, modernization of hospitals, growing demand for diagnostic imaging, and government-supported digital health programs are encouraging technology providers to deliver scalable AI imaging solutions throughout underserved and rapidly developing healthcare markets.

Threat:

Risk of diagnostic errors and algorithm bias

Potential diagnostic inaccuracies and biases in artificial intelligence systems pose an important threat to the Medical Imaging & AI-Enhanced Diagnostics Market. Algorithms developed using narrow or insufficiently diverse datasets may produce inconsistent results across different patient groups, imaging technologies, and healthcare settings. Misclassification of medical images can contribute to missed conditions or unnecessary alerts, potentially affecting clinical outcomes and reducing confidence in AI solutions. Differences in image quality, equipment, and diagnostic procedures can also impact performance. Consequently, healthcare providers may require greater physician supervision, extensive validation, ongoing monitoring, and frequent algorithm updates before widespread implementation.

Covid-19 Impact:

The COVID-19 crisis produced both negative and positive effects on the Medical Imaging & AI-Enhanced Diagnostics Market. Initially, routine examinations and elective imaging procedures decreased considerably as healthcare facilities concentrated on treating infected patients and limiting transmission. At the same time, the crisis encouraged faster adoption of remote radiology, artificial intelligence-based image interpretation, and automated diagnostic processes. AI applications were investigated for COVID-19 screening, triage, and monitoring. Following the pandemic, postponed examinations created substantial imaging demand, while healthcare providers increasingly sought efficient AI-supported solutions to manage diagnostic workloads.

The computed tomography (CT) segment is expected to be the largest during the forecast period

The computed tomography (CT) segment is expected to account for the largest market share during the forecast period. CT has broad applications in emergency medicine, cancer diagnosis, neurological evaluation, cardiovascular care, and trauma management because it delivers detailed images rapidly. The incorporation of AI enhances CT workflows through automated reconstruction, abnormality identification, image segmentation, triage, and quantitative assessment. Strong clinical utility, substantial imaging workloads, established diagnostic processes, and increasing adoption of AI-integrated CT technologies are supporting the segment's leading position within AI-enhanced medical imaging and diagnostic applications.

The diagnostic imaging centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic imaging centers segment is predicted to witness the highest growth rate. Increasing imaging workloads are encouraging these facilities to deploy AI technologies for streamlined workflows, faster reporting, and enhanced abnormality detection. AI tools can automate routine processes, assist radiologists, prioritize urgent examinations, and improve operational efficiency. The expansion of outpatient imaging services and competitive pressure are also motivating diagnostic centers to invest in advanced technologies. Consequently, broader adoption of AI-supported imaging and reporting solutions is expected to accelerate segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. Its dominance is supported by well-developed healthcare systems, advanced imaging infrastructure, and increasing integration of artificial intelligence into diagnostic practices. Significant imaging workloads, healthcare technology spending, and strong research capabilities encourage continued adoption of AI-based solutions. The region also has a large concentration of established imaging companies and specialized AI technology providers, alongside supportive regulatory developments. Growing requirements for faster diagnosis, improved radiology workflows, and technology-assisted clinical decisions are further contributing to North America's leading market position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid modernization of healthcare systems, expanding diagnostic infrastructure, and greater integration of AI into medical imaging are supporting strong regional growth. Increasing demand for diagnostic services, higher healthcare spending, and limited availability of skilled specialists are motivating healthcare organizations to adopt AI-powered imaging technologies. China, India, Japan, and South Korea are key growth markets. Continued digital-health programs, technological innovation, improving healthcare accessibility, and rising investments in artificial intelligence and imaging infrastructure are expected to sustain regional expansion.

Key players in the market

Some of the key players in Medical Imaging & AI-Enhanced Diagnostics Market include GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems, Fujifilm Holdings Corporation, Hologic, Inc., Samsung Medison, Bracco Imaging S.p.A., Aidoc, Qure.ai, Viz.ai, Lunit Inc., Tempus Labs, HeartFlow, Inc., Enlitic, Inc., Nanox.AI, Butterfly Network, Inc. and Riverain Technologies.

Key Developments:

In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc, to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women's health.

In February 2026, Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for those disease states and expand access to new imaging and interventional technologies.

Imaging Modalities Covered:

• X-Ray Imaging
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound Imaging
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)
• Hybrid Imaging

AI Functionalities Covered:

• Image Acquisition Optimization
• Image Reconstruction & Enhancement
• Computer-Aided Detection (CAD)
• Computer-Aided Diagnosis (CADx)
• Workflow Automation & Triage
• Predictive Analytics & Risk Stratification
• Clinical Decision Support Systems

Deployment Models Covered:

• On-Premise Solutions
• Cloud-Based Solutions
• Hybrid Deployment

Applications Covered:

• Oncology
• Cardiology
• Neurology
• Orthopedics
• Gastroenterology
• Pulmonology
• Obstetrics & Gynecology
• General Radiology

End Users Covered:

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Research & Academic Institutes
• Pharmaceutical & Biotech Companies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Imaging Modality

• 5.1 X-Ray Imaging
• 5.2 Computed Tomography (CT)
• 5.3 Magnetic Resonance Imaging (MRI)
• 5.4 Ultrasound Imaging
• 5.5 Positron Emission Tomography (PET)
• 5.6 Single Photon Emission Computed Tomography (SPECT)
• 5.7 Hybrid Imaging

6 Global Medical Imaging & AI-Enhanced Diagnostics Market, By AI Functionality

• 6.1 Image Acquisition Optimization
• 6.2 Image Reconstruction & Enhancement
• 6.3 Computer-Aided Detection (CAD)
• 6.4 Computer-Aided Diagnosis (CADx)
• 6.5 Workflow Automation & Triage
• 6.6 Predictive Analytics & Risk Stratification
• 6.7 Clinical Decision Support Systems

7 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Deployment Model

• 7.1 On-Premise Solutions
• 7.2 Cloud-Based Solutions
• 7.3 Hybrid Deployment

8 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Application

• 8.1 Oncology
• 8.2 Cardiology
• 8.3 Neurology
• 8.4 Orthopedics
• 8.5 Gastroenterology
• 8.6 Pulmonology
• 8.7 Obstetrics & Gynecology
• 8.8 General Radiology

9 Global Medical Imaging & AI-Enhanced Diagnostics Market, By End User

• 9.1 Hospitals & Clinics
• 9.2 Diagnostic Imaging Centers
• 9.3 Research & Academic Institutes
• 9.4 Pharmaceutical & Biotech Companies

10 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 GE HealthCare
• 13.2 Siemens Healthineers
• 13.3 Koninklijke Philips N.V.
• 13.4 Canon Medical Systems
• 13.5 Fujifilm Holdings Corporation
• 13.6 Hologic, Inc.
• 13.7 Samsung Medison
• 13.8 Bracco Imaging S.p.A.
• 13.9 Aidoc
• 13.10 Qure.ai
• 13.11 Viz.ai
• 13.12 Lunit Inc.
• 13.13 Tempus Labs
• 13.14 HeartFlow, Inc.
• 13.15 Enlitic, Inc.
• 13.16 Nanox.AI
• 13.17 Butterfly Network, Inc.
• 13.18 Riverain Technologies